Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study for LDL Apheresis Using H.E.L.P. Therapy

NCT00916643 is registered in ClinicalTrials.gov with B. Braun Medical Inc. as lead sponsor.

NCT NCT00916643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00916643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study for LDL Apheresis Using H.E.L.P. Therapy
Lead sponsor
B. Braun Medical Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1999
Completion date
September 30, 2009
Enrollment
113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia